Analyse patient-level heterogeneity in Alzheimer's Disease using multimodal normative modelling.

Individualized normative maps of brain atrophy, amyloid and tau loading highlight the heterogeneous effect of AD on the brain. The disease severity index based on regional outlier estimates can be potentially used to track an individual's disease progression or treatment response in clinical trials.